# A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

> **NCT05993806** · PHASE1 · COMPLETED · sponsor: **Celltrion** · enrollment: 50 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** L04RD1
- **DRUG:** L04TD3

## Key facts

- **NCT ID:** NCT05993806
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2023-06-12
- **Final completion:** 2023-06-29
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05993806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05993806, "A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05993806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*